KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Gains from Sales and Divestitures: 2016-2019

  • CareDx's Gains from Sales and Divestitures was N/A to $439,704 in Q2 2019 from the same period last year, while for Jun 2019 it was $439,704, marking a year-over-year change of. This contributed to the annual value of $272,806 for FY2018, which is N/A change from last year.
  • As of Q2 2019, CareDx's Gains from Sales and Divestitures stood at $439,704, which was up 58.76% from $276,954 recorded in Q1 2019.
  • In the past 5 years, CareDx's Gains from Sales and Divestitures ranged from a high of $439,704 in Q2 2019 and a low of $26,550 during Q1 2016.
  • Over the past 2 years, CareDx's median Gains from Sales and Divestitures value was $276,954 (recorded in 2019), while the average stood at $329,821.